When compared with other biologic therapies, patients with psoriasis receiving IL-23 inhibitors had a lower risk for inflammatory arthritis or psoriatic arthritis development.
Psoriasis is a chronic inflammatory condition that leads to changes in the skin. In some cases, it can lead to psoriatic arthritis (PsA), which affects the joints. A person with PsA may have ...